Understanding COVID-19 Risk in Patients with Immune Mediated Inflammatory Diseases: A Population-based analysis of SARS-CoV-2 Testing.

Lihi EderRuth CroxfordAaron M DruckerArielle MendelBindee KuriyaZahi Touma Sindhu R JohnsonRichard CookSasha BernatskyNigil HaroonJessica Widdifield

Published in: Arthritis care & research (2021)

Patients across all IMIDs were more likely to be tested for SARS-CoV-2 versus those without IMIDs. The risk of SARS-CoV-2 infection varied across disease sub-groups.

Keyphrases

sars cov
respiratory syndrome coronavirus
end stage renal disease
coronavirus disease
ejection fraction
newly diagnosed
chronic kidney disease
oxidative stress
prognostic factors
patient reported outcomes